Diagnosis and treatment of hyponatremia

American Journal of Kidney Diseases

Volumn 64, Issue 5, 2014, Pages 681-684

  Adrogué, Horacio J ^a   Madias, Nicolaos E ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; POTASSIUM; SODIUM; SODIUM CHLORIDE; THYROID HORMONE;

BRAIN DISEASE; CLINICAL ASSESSMENT; CRYSTALLOID; DEMYELINATION; ELECTROLYTE BLOOD LEVEL; ELECTROLYTE URINE LEVEL; FLUID INTAKE; GLUCOCORTICOID DEFICIENCY; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPONATREMIA; HYPOTHYROIDISM; HYPOVOLEMIA; INAPPROPRIATE VASOPRESSIN SECRETION; MORBIDITY; MORTALITY; PATHOGENESIS; POTASSIUM BLOOD LEVEL; POTASSIUM DEPLETION; POTASSIUM URINE LEVEL; PRACTICE GUIDELINE; REVIEW; SODIUM BLOOD LEVEL; SODIUM URINE LEVEL; URINE OSMOLALITY; FEMALE; MALE;

FEMALE; HUMANS; HYPONATREMIA; MALE;

EID: 84908495307     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2014.06.001     Document Type: Editorial

References (15)

1. R. Wald, B.L. Jaber, L.L. Price, A. Upadhyay, and N.E. Madias Impact of hospital-associated hyponatremia on selected outcomes Arch Intern Med 170 2010 294 302
2. H.J. Adrogué, and N.E. Madias Hyponatremia N Engl J Med 342 2000 1581 1589
3. H.J. Adrogué, and N.E. Madias The challenge of hyponatremia J Am Soc Nephrol 23 2012 1140 1148
4. G. Spasovski, R. Vanholder, and B. Allolio Clinical practice guideline on diagnosis and treatment of hyponatremia Eur J Endocrinol 170 2014 G1 G47
5. G. Spasovski, R. Vanholder, and B. Allolio Clinical practice guideline on diagnosis and treatment of hyponatremia Intensive Care Med 40 2014 320 331
6. G. Spasovski, R. Vanholder, and B. Allolio Clinical practice guideline on diagnosis and treatment of hyponatremia Nephrol Dial Transplant 29 suppl 2 2014 i1 i39
7. J.G. Verbalis, S.R. Goldsmith, and A. Greenberg Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations Am J Med 126 10 suppl 1 2013 S1 S42
8. H.K. Mohmand, D. Issa, Z. Ahmad, J.D. Cappuccio, R.W. Kouides, and R.H. Sterns Hypertonic saline for hyponatremia: risk of inadvertent overcorrection Clin J Am Soc Nephrol 2 2007 1110 1117
9. H.J. Adrogué, and N.E. Madias Aiding fluid prescription for the dysnatremias Intensive Care Med 23 1997 309 316
10. G. Liamis, M. Kalogirou, V. Saugos, and M. Elisaf Therapeutic approach in patients with dysnatremias Nephrol Dial Transplant 21 2006 1564 1569
11. I. Sood, R.H. Sterns, J.K. Hix, S.M. Silver, and I. Chen Hypertonic saline and desmopressin: a simple strategy for safe correction of severe hyponatremia Am J Kidney Dis 61 2012 571 578
12. T. Berl, and A. Rastegar A patient with severe hyponatremia and hypokalemia: osmotic demyelination following potassium repletion Am J Kidney Dis 55 2010 742 748
13. B.L. Jaber, L. Almarzouqi, I. Borgi, V.F. Seabra, E.M. Balk, and N.E. Madias Short-term efficacy and safety of vasopressin receptor antagonists for treatment of hyponatremia Am J Med 124 2011 977.e1 977.e9
14. R.W. Schrier, P. Gross, and M. Gheorghiade Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia N Engl J Med 355 2006 2099 2112
15. M.A. Konstam, M. Gheorghiade, and J.C. Burnett Jr. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial JAMA 297 2007 1319 1331